← Ticker index
WBA
Ticker
WBA
Congressional Trades
29
by 5 members
Ticker disclosure brief
Congressional disclosure records for WBA
A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.
Latest receipt
Valerie Hoyle
SELL · 2025-08-27
Largest range
$50K – $100K
Tommy Tuberville
Longest observed gap
112d
Tommy Tuberville
Highest 30d vs SPY
19.4%
Julie Johnson
Purchase rows
15
52%
Sale rows
14
48%
Disclosed midpoint
$464K
range estimate
Unique Traders
5
members
Disclosure timing method
Observed filing gaps are not notice-date findings
The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.
Party Breakdown
Democrats19 · 66%
Republicans10 · 34%
Lobbying filings
all →- 2026-04-20$0WALGREENS CO.
- 2026-04-19$50KWALGREENS CO.Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues related to vaccines; Issues related to the FDA certification process; Issues related to Pharmacy Benefit Managers. Issues related to pharmacies, pharmacists, and Medicare reimbursement; Issues related to the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to Pharmacy Benefit Managers. Issues related to corporate tax, net operating loss, EBITA/EBIDA.
- 2026-01-20$0WALGREENS CO.
- 2026-01-19$50KWALGREENS CO.Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues related to vaccines; Issues related to the FDA certification process; Issues related to Pharmacy Benefit Managers. Issues related to pharmacies, pharmacists, and Medicare reimbursement; Issues related to the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to Pharmacy Benefit Managers. Issues related to corporate tax, net operating loss, EBITA/EBIDA.
- 2025-10-20$0WALGREENS CO.
- 2025-10-18$50KWALGREENS CO.Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues related to vaccines; Issues related to the FDA certification process; Issues related to Pharmacy Benefit Managers. Issues related to pharmacies, pharmacists, and Medicare reimbursement; Issues related to the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to Pharmacy Benefit Managers. Issues related to corporate tax, net operating loss, EBITA/EBIDA.
- 2025-07-21$0WALGREENS CO.
- 2025-07-18$50KWALGREENS CO.Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA certification process; Issues related to Pharmacy Benefit Managers. Issues related to pharmacies, pharmacists, and Medicare reimbursement; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers. Issues related to corporate tax, net operating loss, EBITA/EBIDA.
- 2025-04-21$0WALGREENS CO.
- 2025-04-16$50KWALGREENS CO.Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA certification process; Issues related to Pharmacy Benefit Managers. Issues related to pharmacies, pharmacists, and Medicare reimbursement; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers. Issues related to corporate tax, net operating loss, EBITA/EBIDA.
Loading trade analytics…
All Disclosed Trades
Page 1 · 25 of 29 shown| Date | Member | Action | Amount | Observed Gap | Receipt |
|---|---|---|---|---|---|
| 2025-08-27 | DValerie Hoyle | SELL | $1K – $15K | 19d | receipt → |
| 2025-08-27 | DValerie Hoyle | SELL | $1K – $15K | 16d | receipt → |
| 2025-08-27 | DValerie Hoyle | SELL | $1K – $15K | 16d | receipt → |
| 2025-02-12 | DJulie Johnson | SELL | $1K – $15K | 28d | receipt → |
| 2025-02-12 | DJulie Johnson | SELL | $1K – $15K | 28d | receipt → |
| 2025-02-26 | DGilbert Cisneros | SELL | $1K – $15K | 8d | receipt → |
| 2025-02-26 | DGilbert Cisneros | SELL | $1K – $15K | 8d | receipt → |
| 2025-02-26 | DGilbert Cisneros | SELL | $1K – $15K | 6d | receipt → |
| 2025-02-26 | DGilbert Cisneros | BUY | $1K – $15K | 6d | receipt → |
| 2025-01-15 | DJulie Johnson | BUY | $1K – $15K | 28d | receipt → |
| 2025-01-15 | DJulie Johnson | BUY | $1K – $15K | 28d | receipt → |
| 2024-08-02 | DRo Khanna | BUY | $1K – $15K | 35d | receipt → |
| 2024-08-02 | DRo Khanna | BUY | $1K – $15K | 35d | receipt → |
| 2024-07-01 | DRo Khanna | BUY | $1K – $15K | 37d | receipt → |
| 2024-07-01 | DRo Khanna | BUY | $1K – $15K | 37d | receipt → |
| 2024-04-30 | RTommy Tuberville | SELL | $50K – $100K | 15d | receipt → |
| 2024-04-30 | RTommy Tuberville | SELL | $50K – $100K | 15d | receipt → |
| 2024-03-21 | RTommy Tuberville | BUY | $15K – $50K | 26d | receipt → |
| 2024-03-21 | RTommy Tuberville | BUY | $15K – $50K | 25d | receipt → |
| 2024-03-21 | RTommy Tuberville | BUY | $15K – $50K | 25d | receipt → |
| 2024-03-20 | DRo Khanna | SELL | $1K – $15K | 16d | receipt → |
| 2024-03-25 | DRo Khanna | SELL | $1K – $15K | 11d | receipt → |
| 2024-03-20 | DRo Khanna | SELL | $1K – $15K | 16d | receipt → |
| 2024-03-25 | DRo Khanna | SELL | $1K – $15K | 11d | receipt → |
| 2023-05-08 | RTommy Tuberville | BUY | $1K – $15K | 112dApparent delay | receipt → |
“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.